Active Pharmaceutical Ingredients - Dr Reddy's
Active Pharmaceutical Ingredients - Dr Reddy's

About Empagliflozin API

Product
  • Therapeutic Category 抗糖尿病

  • CAS Number

    864070-44-0

  • API Technology

    Synthetic

  • Dose Form

    Liquid

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, EUDMF, Korea DMF, Canada DMF, Singapore DMF, Australia DMF, Saudi Arabia, Malaysia DMF

Mechanism of Action

Sodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion.

Indication

JARDIANCE is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated:

  • As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,
  • To reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Country *
Select Product *
Select Regulatory Requirements
Select Purpose

Related APIs

ダパグリフロジン(非晶質)

抗糖尿病

arrow

ピオグリタゾン塩酸塩

抗糖尿病

arrow

リラグルチド

抗糖尿病

arrow

グリメピリド

抗糖尿病

arrow

Semaglutide

抗糖尿病

arrow

ダパグリフロジン(プロ パンジオール一水和物)

抗糖尿病

arrow

シタグリプチン塩酸塩( 一水和物

抗糖尿病

arrow

エンパグリフロジン

抗糖尿病

arrow

リナグリプチン(AB型)

抗糖尿病

arrow

シタグリプチンリン酸エステル(無水物)

抗糖尿病

arrow

シタグリプチン塩酸塩( 一水和物)

抗糖尿病

arrow

免責事項

No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.